BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23828856)

  • 1. Quantitative metabolic profiling of lipid mediators.
    Balgoma D; Checa A; Sar DG; Snowden S; Wheelock CE
    Mol Nutr Food Res; 2013 Aug; 57(8):1359-77. PubMed ID: 23828856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid mediators and their metabolism in the nucleous: implications for Alzheimer's disease.
    Farooqui AA
    J Alzheimers Dis; 2012; 30 Suppl 2():S163-78. PubMed ID: 21955817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid mediator profiling in pulmonary disease.
    Lundström SL; Balgoma D; Wheelock ÅM; Haeggström JZ; Dahlén SE; Wheelock CE
    Curr Pharm Biotechnol; 2011 Jul; 12(7):1026-52. PubMed ID: 21466458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders.
    Farooqui AA
    Neuroscientist; 2009 Aug; 15(4):392-407. PubMed ID: 19666894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent effect of in vivo inflammation on eicosanoid and endocannabinoid levels in plasma, liver, ileum and adipose tissue in C57BL/6 mice fed a fish-oil diet.
    Balvers MG; Verhoeckx KC; Meijerink J; Bijlsma S; Rubingh CM; Wortelboer HM; Witkamp RF
    Int Immunopharmacol; 2012 Jun; 13(2):204-14. PubMed ID: 22498761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidomics era: accomplishments and challenges.
    Bou Khalil M; Hou W; Zhou H; Elisma F; Swayne LA; Blanchard AP; Yao Z; Bennett SA; Figeys D
    Mass Spectrom Rev; 2010; 29(6):877-929. PubMed ID: 20931646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive lipid mediators in skin inflammation and immunity.
    Kendall AC; Nicolaou A
    Prog Lipid Res; 2013 Jan; 52(1):141-64. PubMed ID: 23124022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioanalytical insights into mediator lipidomics.
    Kasuga K; Suga T; Mano N
    J Pharm Biomed Anal; 2015 Sep; 113():151-62. PubMed ID: 25769667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidomic analysis of signaling pathways.
    Wakelam MJ; Pettitt TR; Postle AD
    Methods Enzymol; 2007; 432():233-46. PubMed ID: 17954220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane lipids as signaling molecules.
    Fernandis AZ; Wenk MR
    Curr Opin Lipidol; 2007 Apr; 18(2):121-8. PubMed ID: 17353659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acids and related lipid mediators in the regulation of cutaneous inflammation.
    Kiezel-Tsugunova M; Kendall AC; Nicolaou A
    Biochem Soc Trans; 2018 Feb; 46(1):119-129. PubMed ID: 29330355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles of bioactive lipid signalling: lessons from sphingolipids.
    Hannun YA; Obeid LM
    Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediator lipidomics.
    Serhan CN
    Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):4-14. PubMed ID: 16099386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention.
    Tai CC; Ding ST
    J Nutr Biochem; 2010 May; 21(5):357-63. PubMed ID: 20149625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism.
    Akyol S; Ugur Z; Yilmaz A; Ustun I; Gorti SKK; Oh K; McGuinness B; Passmore P; Kehoe PG; Maddens ME; Green BD; Graham SF
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of bioactive lipid mediators in human skin.
    Kendall AC; Pilkington SM; Massey KA; Sassano G; Rhodes LE; Nicolaou A
    J Invest Dermatol; 2015 Jun; 135(6):1510-1520. PubMed ID: 25668241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics.
    Sullards MC; Allegood JC; Kelly S; Wang E; Haynes CA; Park H; Chen Y; Merrill AH
    Methods Enzymol; 2007; 432():83-115. PubMed ID: 17954214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidomics of Bioactive Lipids in Alzheimer's and Parkinson's Diseases: Where Are We?
    Chiurchiù V; Tiberi M; Matteocci A; Fazio F; Siffeti H; Saracini S; Mercuri NB; Sancesario G
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players.
    Lambert DM; Muccioli GG
    Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):735-44. PubMed ID: 18089956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.
    Chiurchiù V; Leuti A; Maccarrone M
    Front Immunol; 2018; 9():38. PubMed ID: 29434586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.